
CAS 1911644-32-0
:1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
Description:
1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- is a chemical compound characterized by its complex structure, which includes a pyrazole ring and a pyrrolopyrimidine moiety. This compound is typically classified as an organic heterocyclic compound due to the presence of nitrogen atoms in its ring systems. It exhibits properties such as potential biological activity, making it of interest in medicinal chemistry and drug development. The presence of the cyclopentyl group may influence its lipophilicity and overall pharmacokinetic profile. Additionally, the compound's amide functional group can contribute to its solubility and stability in various solvents. Its specific interactions with biological targets can be explored through various assays, and its structure-activity relationship can provide insights into its efficacy and safety profile. Overall, this compound represents a unique scaffold that may have applications in therapeutic contexts, particularly in the development of novel pharmaceuticals.
Formula:C17H20N6O
Synonyms:- 1H-Pyrazole-1-propanamide, β-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
- Ruxolitinib Impurity 25
- Ruxolitinib Impurity 6
- Ruxolitinib-amide
- Ruxolitinib-amideQ: What is
- Ruxolitinib-amide Q: What is the CAS Number of
- Ruxolitinib-amide Q: What is the storage condition of
- Ruxolitinib Impurity 5
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamide
CAS:3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanamidePurity:98%Molecular weight:324.39g/molRuxolitinib Impurity 6
CAS:Formula:C17H20N6OColor and Shape:White To Off-White SolidMolecular weight:324.39Ruxolitinib-amide
CAS:Controlled Product<p>Applications Ruxolitinib-amide is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.<br>References Shilling, A.D. et al.: Drug Metab. Disp., 38, 2023 (2010); Mesa, R.A.: IDrugs, 13, 394 (2010); Campas-Moya, C.: Drugs Fut., 35, 457 (2010);<br></p>Formula:C17H20N6OColor and Shape:NeatMolecular weight:324.38RuxoRuxolitinib amidelitinib-amide
CAS:<p>RuxoRuxolitinib amidelitinib-amide is a drug product that is used in the development of new drugs. This synthetic compound has been shown to have cytotoxic activity in vitro and in vivo against cancer cells. The active metabolite of this drug product, desacetylruxolitinib, has been shown to suppress platelet activation and inhibit the growth of erythrocytes. RuxoRuxolitinib amidelitinib-amide is an impurity standard for analytical purposes and an API impurity. It also has been shown to have pharmacological effects on the liver and kidneys, as well as having toxic effects on red blood cells. RuxoRuxolitinib amidelitinib-amide is not found in any pharmacopoeia because it is a synthetic compound.</p>Formula:C17H20N6OPurity:Min. 95%Molecular weight:324.38 g/mol






